TITLE

Nocturnal oxyhaemoglobin desaturation and plasminogen activator inhibitor type-1 in patients with diastolic dysfunction

AUTHOR(S)
Pencic, B.; Dekleva, M.; Celic, V.; Grdinic, A.; Ilic, I.; Backovic, S.; Caparevic, Z.; Jelic, S.; Kostic, N.
PUB. DATE
June 2008
SOURCE
European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p132
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Nocturnal oxyhaemoglobin desaturation and plasminogen activator inhibitor type-1 in patients with diastolic dysfunction," by B. Pencic and colleagues is presented.
ACCESSION #
36113809

 

Related Articles

  • Heparin.  // Reactions Weekly;1/16/2016, Vol. 1584 Issue 1, p115 

    An abstract of the article "Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis" by M. El-Segaier and others, is presented.

  • 215. Investigating Urokinase Plasminogen Activator Receptor (CD87), as a Potential Target for Non-Viral Gene Transfer Thanou, Maya; Kean, Thomas // Molecular Therapy;Jun2005, Vol. 11, p85 

    An abstract of the article "Investigating Urokinase Plasminogen Activator Receptor (CD87), as a Potential Target for Non-Viral Gene Transfer," by Maya Thanou and Thomas Kean is presented.

  • Serum plasminogen activator inhibitor 1 (PAI-1) and intra-ocular pressure (IOP): the Guangzhou biobank cohort study. Heggie, J.; Tanner, K.; Protty, M.; Thomas, G. N. // BMC Proceedings;2012 Supplement 4, Vol. 6 Issue Suppl 4, p1 

    An abstract of the article "Serum plasminogen activator inhibitor 1 (PAI-1) and intra-ocular pressure (IOP): the Guangzhou biobank cohort study," by J. Heggie, K. Tanner, M. Protty, and G. N. Thomas is presented.

  • MECHANISM OF DIFFERENT ACTIVATORS OF PPARαREGULATING PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION.  // Heart;Oct2010 Supplement, pA47 

    An abstract of the article "Mechanism of Different Activators of PPARα-Regulating Plasminogen Activator Inhibitor-1 Expression" by Chen Jing and colleagues is presented.

  • P157 - INVESTIGATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 4G/5G GENE POLIMORPHISIM IN PATIENTS PRE-DIAGNOSED WITH CEREBROVASCULAR DISEASE, COAGULATION DISORDER AND HYPERTENSION. DÖNDER, Ahmet; BALAHOROĞLU, Ragıp; ŞEKEROĞLU, Mehmet Ramazan; DÜLGER, Haluk // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;2012 Special Issue, Vol. 37 Issue S1, p298 

    Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease. The polymorphism of the 4G/5G gene is located in the PAI-1 gene promoter region. In this study, our objective is to investigate the...

  • Aspirin/heparin/plasminogen activators.  // Reactions Weekly;Nov2014, Vol. 1526 Issue 1, p28 

    An abstract of the article "Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy," by A. K. Vellimana and colleagues is presented.

  • Patients with Mild Ischemic Stroke Benefit from IV-rtPA. Vinall, Phil // MD Conference Express;Jun2014, Vol. 14 Issue 6, p14 

    There has been considerable debate regarding the use of intravenous recombinant tissue plasminogen activator (IV-rtPA) in patients with mild stroke symptoms. It has been unclear whether the potential benefits of improvement in neurologic outcomes outweigh the potential risks of hemorrhagic...

  • Neurovascular Disorders.  // Current Medical Literature: Neurology;2007, Vol. 23 Issue 4, p112 

    The article presents abstracts on neurovascular disorders including the risk factors of symptomatic intracerebral hemorrhage following tissue plasminogen activator (tPA) therapy for acute stroke, an analysis of spontaneous brain microbleeds and a review of silent brain infarcts.

  • Acute Stroke Treatment.  // Current Medical Literature: Stroke Review;2006, Vol. 10 Issue 1, p15 

    The article presents abstracts of medical research related to acute stroke treatment. They include "Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience," "In-hospital medical complications and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics